In fiscal year 2022, CKD Bio (063160) reported revenue of 156.0 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2022 | 156.0 billion KRW | -14.8 billion KRW | -16.7 billion KRW | [source] |
| 2021 | 142.2 billion KRW | -11.4 billion KRW | -6.6 billion KRW | [source] |
| 2020 | 124.6 billion KRW | 7.6 billion KRW | 6.2 billion KRW | — |
| 2019 | 137.2 billion KRW | 15.4 billion KRW | 12.3 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2022 | 312.5 billion KRW | 164.6 billion KRW | 147.9 billion KRW | [source] |
| 2021 | 296.7 billion KRW | 136.7 billion KRW | 160.0 billion KRW | [source] |
| 2020 | — | — | — | — |
| 2019 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.